Pharmaceuticals

Top US court to rule on pact among pharma firms to delay generics launch

08 Dec 2012

Strides Arcolab, Eli Lilly to collaborate on cancer drug delivery

05 Dec 2012

Baxter International to buy Swedish dialysis product company Gambro for $4 bn

04 Dec 2012

Nestle forms JV with Li Ka-Shing’s Chi-Med for developing gastro treatment based on traditional Chinese medicine

29 Nov 2012

AstraZeneca loses appeal on lung cancer drug rights in India

28 Nov 2012

Smith & Nephew to buy privately-held Healthpoint for $782 million

28 Nov 2012

67-year old Mumbai patient implanted with the first MRI compatible CRT-D in India

27 Nov 2012

Ranbaxy recalls generic Lipitor in US market over glass particles in bottles

24 Nov 2012

Pfizer cuts Viagra price in Canada after losing patent case

23 Nov 2012

Essential drug prices to fall as GoM approves new pricing policy

22 Nov 2012

Cipla offers to acquire controlling stake in Cipla Medpro South Africa for $220 million

21 Nov 2012

Novartis receives FDA approval to make first cell-culture vaccine in US for seasonal influenza

21 Nov 2012

Bayer backs out from bidding war with Reckitt Benckiser over US vitamins maker Schiff Nutrition

20 Nov 2012

Canadian life sciences company SQI Diagnostics explores sale

20 Nov 2012

Allergan to buy SkinMedica’s skin care unit for $350 million

19 Nov 2012

GVK BIO sets up India's largest lsotope labeling facility

19 Nov 2012

Biocon in pact with Bristol-Myers Squibb for oral insulin

16 Nov 2012

Sun Pharma to buy US dermatology company Dusa Pharmaceuticals for $230 mn

09 Nov 2012

Boston Scientific to buy Vessix Vascular in a $425 million deal

09 Nov 2012

Cipla slashes prices of three more cancer drugs

08 Nov 2012

Cipla has halved, and in some cases cut prices by more than 60 per cent, on the three anti-cancer drugs meant for the treatment of lung and pancreatic cancer, breast cancer, head and neck cancer, gastric cancer, bladder, colorectal and colon cancers

Astex Pharmaceuticals in drug discovery pact with Cancer Research Technology, Newcastle University

31 Oct 2012

Biocon announces positive results from its global phase 3 study with recombinant human insulin

31 Oct 2012

GE Capital to invest Rs125 crore in Biocon’s subsidiary Syngene International

31 Oct 2012

Allergan explores sale of obesity intervention business

31 Oct 2012

Bayer to buy US vitamins maker Schiff Nutrition International for $1.2 bn

30 Oct 2012